(R)-2-(2-(((Benzyloxy)carbonyl)amino)propanamido)acetic acid, 95.0%, 5g

tert-Butyl 1,4,5,7-tetrahydro-6H-pyrrolo[2,3-c]pyridine-6-carboxylate, 1g

8-Bromo-3,4-dihydrobenzo[f][1,4]oxazepin-5(2H)-one, 95%, 5g

Tris(2-ethylhexyl) 4,4',4''-((1,3,5-triazine-2,4,6-triyl)tris(azanediyl))tribenzoate, 97.0%, 10g

tert-Butyl 4-(2-hydroxyethyl)piperazine-1-carboxylate, 95.0%, 5g

Di-potassium hydrogen phosphate, min. 98%, Ph.Eur., anhydrous, 500 g, plastic packaging.

tert-Butyl 2-oxo-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5,6-dihydropyridine-1(2H)-carboxylate, 98%, 10g

Fmoc-Glu-(Boc)-Val-Cit-PAB-PNP, 100mg

Benzyl beta-D-glucopyranoside, 98%, 2g

TERT-BUTYL 2-BROMO-5-FLUOROBENZOATE, 95.0%, 1g

N-TIGLOYLGLYCINE, 97.0%, 10mg

Trimethoxy(3,3,3-trifluoropropyl)silane>98.0%(GC)25g

(4-Hydroxy-3-methoxyphenyl)boronic acid, 95.0%, 1g